Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

‘Strategic Decision’ Prompts Janssen Exit From Chi-Med Deal

This article was originally published in PharmAsia News

Executive Summary

One of the largest collaborative deals in China’s pharmaceutical industry has fallen apart, as Janssen has opted to terminate an R&D alliance agreement in the inflammation/immunology area with Hutchison China MediTech, although the two firms intend to continue to work together in other areas.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register